unable to tolerate the standard treatment of angiotensin-converting enzyme (ACE) inhibitors.
Telmisartan Modestly Reduces Major Cardiovascular Events In Patients Unable To Tolerate Ace Inhibitors (Transcend Study)
Posted by in Health on 08 31st, 2008 | no responses
The angiotensin-receptor blocker (ARB) telmisartan should be regarded as a potential treatment for vascular disease or high-risk diabetes, in the 20% of patients who are
Original post by Women’s Health / Gynecology News From Medical News Today
Leave a Reply
